U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H16O8
Molecular Weight 336.2934
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of 5-CAFFEOYLSHIKIMIC ACID

SMILES

O[C@@H]1C=C(C[C@@H](OC(=O)\C=C\C2=CC=C(O)C(O)=C2)[C@@H]1O)C(O)=O

InChI

InChIKey=QMPHZIPNNJOWQI-GDDAOPKQSA-N
InChI=1S/C16H16O8/c17-10-3-1-8(5-11(10)18)2-4-14(20)24-13-7-9(16(22)23)6-12(19)15(13)21/h1-6,12-13,15,17-19,21H,7H2,(H,22,23)/b4-2+/t12-,13-,15-/m1/s1

HIDE SMILES / InChI

Description

5-O-Caffeoylshikimic acid is a characteristic phenolic compound mainly found in the Palmae family. 5-O-Caffeoylshikimic acid was isolated from such plants as Vaccinium corymbosum, Livistona chinensis to name a few. The drug demonstrated the antiproliferative activity against different cancer cell lines. 5-O-Caffeoylshikimic acid could promote cancer cell apoptosis and block cancer cell adhesion, invasion and migration by inhibiting transforming growth factor beta 1 (TGF-beta1) signaling pathway.

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
In a macrophages migration and adhesion assay, HUVEC were cultured in DMEM supplemented with 10% FBS, 1% penicillin-streptomycin, at 37C in a 5% CO2 incubator. Then HUVEC were seeded on the coverslips in 24-well plates at 80–90% confluence, starved and incubated with 5-O-Caffeoylshikimic acid (5 uM; 500 nM; 50 nM) + advanced glycation end-products (200 ug/mL) for 24 h.